Next-generation sequencing has become a powerful tool for testing genetically and clinically heterogeneous conditions such as mitochondrial disorders. A recent study published in Science Translational Medicine underscores the considerable clinical benefits of targeted next-generation sequencing for the diagnosis of mitochondrial disorders. The findings also suggest that the genetic heterogeneity that can result in mitochondrial disease appears much broader than previously thought. © 2012 BioMed Central Ltd.
CITATION STYLE
Hahn, S. H. (2012, March 23). Targeted next-generation sequencing expands the spectrum of mitochondrial disorders. Genome Medicine. https://doi.org/10.1186/gm321
Mendeley helps you to discover research relevant for your work.